
European Journal of Medicinal Chemistry p. 547 - 570 (1997)
Update date:2022-08-04
Topics:
Griera
Armengol
Reyes
Alvarez
Palomer
Cabre
Pascual
Garcia
Mauleon
This paper describes the synthesis and pharmacological evaluation of three series of compounds 4a-b, 13a-k and 19, structurally related to the known potent cysLT1 receptor antagonists RG-12553, IC1-204219 and ONO-1078, respectively. The common structural feature of these new series is the presence of a 4-quinolone nucleus acting as a template for substitution of the aromatic nucleus present in the prototype antagonists. We describe the evolution of these series leading to antagonists with potency at nanomolar concentrations in vitro.
View MoreTaizhou Blazer Biomedical Technology Co., Ltd.
Contact:0523-86112008
Address:Gaogang district Chuangye road.
Anhui Sholon New Material Technology Co., Ltd.
website:http://www.sholonchem.com
Contact:+86-550-5261666
Address:4/F Block B, Beijing Chemical Building.No.520 Tianrun Road ,Science & Education Town Wujin District, Changzhou City Jiangsu Province
WUXI KINGHAN BIO-MEDICAL&CHEMICAL INC.
Contact:13861062998
Address:Room 1316,No.1619 Huishan Avenue,Wuxi,China
Nantong Kaixin Pharma Chemical Co.,Ltd.
Contact:86-513-85250786
Address:2-1103 Huachen Mansion, 111 Gongnong Road,Nantong, Jiangsu, China
Shanghai Dynamic Industrial Co.,Ltd.
website:http://www.shdynamic.com
Contact:86-021 3392 6680
Address:Room 805 Information Tower, No.1403 Minsheng Road, Pudong New Area, Shanghai 200135, P. R. China
Doi:10.1021/om5002217
(2014)Doi:10.1021/jo01144a018
(1951)Doi:10.1021/jm00222a002
(1977)Doi:10.1139/v96-282
(1996)Doi:10.1007/BF00778173
()Doi:10.3390/molecules201018565
(2015)